Vanguard Group Inc

13F Holdings History for Avidity Biosciences, Inc. - COMMON STOCK (RNA)

Symbol: RNA on Nasdaq
Investment type: Equity / COMMON STOCK
Latest Disclosed Ownership: 13.2M shares
Security Ownership: 9.57%

Shares, Excluding Options vs Price

Value, Excluding Options

The Vanguard Group ownership in Avidity Biosciences, Inc. COMMON STOCK (RNA)

2025-10-30 - The Vanguard Group has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 13.2M shares of Avidity Biosciences, Inc. COMMON STOCK (RNA). This represents 9.57% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
The Vanguard Group	9.57%		$576M	13.2M			$43.57	13G/A	9/30/2025	30 Oct 2025 14:24:31

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	0.01%	+0%	$576M	13.2M	+3,971,457	+42.9%	$43.57	Q3 2025
6/30/2025	0%	+0%	$263M	9.25M	+5,097	+0.06%	$28.40	Q2 2025
3/31/2025	0%	0%	$273M	9.24M	-188,706		$29.52	Q1 2025
12/31/2024	0%	+0%	$274M	9.43M	+205,027	+2.22%	$29.08	Q4 2024
9/30/2024	0.01%	+0%	$424M	9.23M	+3,283,202	+55.2%	$45.93	Q3 2024
6/30/2024	0%	+0%	$243M	5.94M	+2,098,610	+54.6%	$40.85	Q2 2024
3/31/2024	0%	0%	$98.1M	3.85M	-198,107	-4.9%	$25.52	Q1 2024
12/31/2023	0%	+0%	$36.6M	4.04M	+28,689	+0.71%	$9.05	Q4 2023
9/30/2023	0%	+0%	$25.6M	4.01M	+47,305	+1.19%	$6.38	Q3 2023
6/30/2023	0%	+0%	$44M	3.97M	+485,468	+13.9%	$11.09	Q2 2023
3/31/2023	0%	+0%	$53.4M	3.48M	+11,091	+0.32%	$15.35	Q1 2023
12/31/2022	0%	+0%	$77M	3.47M	+772,250	+28.6%	$22.19	Q4 2022
9/30/2022	0%	+0%	$44.1M	2.7M	+276,254	+11.4%	$16.33	Q3 2022
6/30/2022	0%	+0%	$35.2M	2.42M	+123,759	+5.38%	$14.53	Q2 2022
3/31/2022	0%	+0%	$42.5M	2.3M	+294,791	+14.7%	$18.47	Q1 2022
12/31/2021	0%	+0%	$47.6M	2M	+60,959	+3.14%	$23.77	Q4 2021
9/30/2021	0%	+0%	$47.8M	1.94M	+670,815	+52.7%	$24.63	Q3 2021
6/30/2021	0%	0%	$31.4M	1.27M	-11,273	-0.88%	$24.71	Q2 2021
3/31/2021	0%	+0%	$28M	1.28M	+468,745	+57.6%	$21.81	Q1 2021
12/31/2020	0%	+0%	$20.8M	814K	+65,055	+8.68%	$25.52	Q4 2020
9/30/2020	0%	+0%	$21.1M	749K	+729,271	+3646%	$28.15	Q3 2020
6/30/2020	0%	+0%	$565K	20K	+20,000	NEW	$28.25	Q2 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.